BMS Latest Drug Maker to Sue HHS over 340B Rebate Model Shift
- December 06, 2024
Bristol Myers Squibb Co. (BMS) filed November 26 a lawsuit alleging the Department of Health and Human Services (HHS) unlawfully blocked the company’s plan to shift to a rebate model for providing discounts under the 340B program.
ARTICLE TAGS
You must be logged in to access this content.